Skip to main content

and
  1. Article

    Open Access

    Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

    Breast cancer is a complex disease with a highly immunosuppressive tumor microenvironment, and has limited clinical response to immune checkpoint blockade (ICB) therapy. T-helper 2 (Th2) cells, an important co...

    Yuru Chen, Jiazheng Sun, Yachan Luo, Jiazhou Liu in Journal of Translational Medicine (2022)